OpenVSafe by OpenVAERS
Search V-safe

Y67-22830-81705

3 vaccinations 5 coded responses 23 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
447 / OH
Registered
2021-04-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-05
    Registered in v-safe
  3. 2021-04-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Adverse reaction — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: I have had these symptoms for several days. I was better this morning but by afternoon the symptoms returned
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Joint pains, Fatigue or tiredness
    Adult check-in
  6. 2021-04-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-16
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-04-22
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-04-29
    Dose 2 — Pfizer-BioNTech
  10. 2021-04-29
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  11. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  12. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  13. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains
    Adult check-in
  15. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  17. 2021-05-06
    Health check-in — day 7, dose 2
    Feeling: Good · Headache, Joint pains
    Adult check-in
  18. 2021-05-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-05
    Survey response — day 35, dose 2
    MedDRA: Headache, Rash — Feeling: Fair
    Free text: Headaches, then an unexplainable rash started
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-31
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-28
    Survey response — 6 months, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Unusually more joint pain
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-29
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 pneumonia, Disease complication — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Got covid pneumonia back in Jan. Still dealing with complications.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-05-06
    Dose 3 — Moderna
  27. 2022-06-21
    Survey response — day 42, dose 3
    MedDRA: Blood pressure decreased, Cardiac disorder, Confusional state, Dizziness, Dysphonia, Dyspnoea, Hypoaesthesia, Peripheral swelling — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Complications with my heart, continued difficulty breathing, BP drops low, lightheaded and dizzy spells, very weak voice upon physical or mental exertion, numbness & swelling in hands, legs, & feet when I do anything, and mental confusion.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-06-21
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  29. 2022-06-22
  30. 2022-06-24
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-29Pfizer-BioNTech
32022-05-06Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-06-21 Successful
2022-06-24
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-05

Systemic reaction (other): I have had these symptoms for several days. I was better this morning but by afternoon the symptoms returned

Release 8 — day 35, dose 2

2021-06-05

Symptoms: Headaches, then an unexplainable rash started

Release 10 — 6 months, dose 2

2021-10-28

Symptoms: Unusually more joint pain

Release 11 — 12 months, dose 2

2022-04-29

Symptoms: Got covid pneumonia back in Jan. Still dealing with complications.

Release 12 — day 42, dose 3

2022-06-21

Symptoms: Complications with my heart, continued difficulty breathing, BP drops low, lightheaded and dizzy spells, very weak voice upon physical or mental exertion, numbness & swelling in hands, legs, & feet when I do anything, and mental confusion.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood pressure decreased · · ✓
SDCardiac disorder · · ✓
SDCondition aggravated · · ✓
SDConfusional state · · ✓
SDCOVID-19 pneumonia · · ✓
SDDisease complication · · ✓
SDDizziness · · ✓
SDDysphonia · · ✓
SDDyspnoea · · ✓
SDHeadache ✓ ✓ ✓
SDHypoaesthesia · · ✓
SDPeripheral swelling · · ✓
SDPre-existing disease · · ✓
SDRash ✓ ✓ ✓
SROAdverse reaction ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release